Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc. (CODX) Q1 2026 Annual Earnings

CODX·Reported May 14, 2026·After market close

Co-Diagnostics, Inc. reported Q1 2026 revenue of $146.0K (+190.3% YoY), beat analyst consensus of $127.1K by $18.9K. Diluted EPS came in at $-4.06 (-1591.7% YoY), missed the $-3.75 consensus by $0.31.

Revenue
$146.0Kbeat by $18.9K
Consensus: $127.1K
Diluted EPS
$-4.06missed by $0.31
Consensus: $-3.75
SEC

SEC Filings

Earnings release8-K · 0001493152-26-023059
Annual report10-K · 0001493152-26-014158

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Co-Diagnostics, Inc. 's Q1 2026 earnings report.

Co-Diagnostics, Inc. (CODX) reported Q1 2026 earnings on May 14, 2026 after market close.

Co-Diagnostics, Inc. reported revenue of $146.0K and diluted EPS of $-4.06 for Q1 2026.

Revenue beat the consensus estimate of $127.1K by $18.9K. EPS missed the consensus estimate of $-3.75 by $0.31.

Compared to the same quarter a year prior, revenue grew 190.3% from $50.3K a year earlier and diluted EPS declined 1591.7% from $-0.24.

You can read the 8-K earnings release (0001493152-26-023059) and the 10-K periodic report (0001493152-26-014158) directly on SEC EDGAR. The filing index links above go to sec.gov.